Literature DB >> 15335726

Molecular mimicry of the antigen receptor signalling motif by transmembrane proteins of the Epstein-Barr virus and the bovine leukaemia virus.

G Alber1, K M Kim, P Weiser, C Riesterer, R Carsetti, M Reth.   

Abstract

BACKGROUND: Many transmembrane proteins of eukaryotic cells have only a short cytoplasmic tail of 10 - 100 amino acids, which has no obvious catalytic function. These tails are thought to be involved either in signal transduction or in the association of transmembrane proteins with the cytoskeleton. We have previously identified, in the cytoplasmic tails of components of B and T lymphocyte antigen receptors, an amino-acid motif that is required for signalling. The same motif is also found in the cytoplasmic tails of two viral proteins: the latent membrane protein, LMP2A, of Epstein Barr virus and the envelope protein, gp30, of bovine leukaemia virus. Interestingly, both viruses can activate infected B lymphocytes to proliferate, as does signalling by the B-cell receptor.
RESULTS: In this study, we show that the cytoplasmic tails of the two viral proteins, and the cytoplasmic tail of the B-cell receptor immunoglobulin-alpha chain, when linked to CD8 in chimeric transmembrane proteins, can transduce signals in B cells. Cross-linking of these chimeric receptors activates B-cell protein tyrosine kinases and results in calcium mobilization. Furthermore, these cytoplasmic sequences are also protein tyrosine kinase substrates and may interact with cytosolic proteins carrying SH2 protein-protein interaction domains.
CONCLUSION: Our findings suggest that viral transmembrane proteins can mimic the antigen-induced stimulation of the B-cell antigen receptor and thus can influence the activation and/or survival of infected B lymphocytes.

Entities:  

Year:  1993        PMID: 15335726     DOI: 10.1016/0960-9822(93)90196-u

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  20 in total

1.  Deregulated signal transduction by the K1 gene product of Kaposi's sarcoma-associated herpesvirus.

Authors:  M Lagunoff; R Majeti; A Weiss; D Ganem
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

2.  K1 and K15 of Kaposi's Sarcoma-Associated Herpesvirus Are Partial Functional Homologues of Latent Membrane Protein 2A of Epstein-Barr Virus.

Authors:  Lisa Steinbrück; Montse Gustems; Stephanie Medele; Thomas F Schulz; Dominik Lutter; Wolfgang Hammerschmidt
Journal:  J Virol       Date:  2015-05-06       Impact factor: 5.103

3.  Epstein-barr virus latent membrane protein 2B (LMP2B) modulates LMP2A activity.

Authors:  Mark Rovedo; Richard Longnecker
Journal:  J Virol       Date:  2006-10-11       Impact factor: 5.103

4.  Epstein-Barr virus latent membrane protein 2 associates with and is a substrate for mitogen-activated protein kinase.

Authors:  C G Panousis; D T Rowe
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

5.  Role of the proline-rich motif of bovine leukemia virus transmembrane protein gp30 in viral load and pathogenicity in sheep.

Authors:  M Reichert; A Winnicka; L Willems; R Kettmann; G H Cantor
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

6.  Latent membrane protein 2A of Epstein-Barr virus binds WW domain E3 protein-ubiquitin ligases that ubiquitinate B-cell tyrosine kinases.

Authors:  G Winberg; L Matskova; F Chen; P Plant; D Rotin; G Gish; R Ingham; I Ernberg; T Pawson
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

Review 7.  The biology of Hodgkin's lymphoma.

Authors:  Ralf Küppers
Journal:  Nat Rev Cancer       Date:  2008-12-11       Impact factor: 60.716

8.  Dileucine and YXXL motifs in the cytoplasmic tail of the bovine leukemia virus transmembrane envelope protein affect protein expression on the cell surface.

Authors:  Sinisa Novakovic; Earl T Sawai; Kathryn Radke
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

9.  The YXXL signalling motifs of the bovine leukemia virus transmembrane protein are required for in vivo infection and maintenance of high viral loads.

Authors:  L Willems; J S Gatot; M Mammerickx; D Portetelle; A Burny; P Kerkhofs; R Kettmann
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

Review 10.  Epstein-Barr virus: more than 50 years old and still providing surprises.

Authors:  Lawrence S Young; Lee Fah Yap; Paul G Murray
Journal:  Nat Rev Cancer       Date:  2016-09-30       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.